These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 9840568)
41. Vascular reactivity in patients with preeclampsia and HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Fischer T; Schneider MP; Schobel HP; Heusser K; Langenfeld M; Schmieder RE Am J Obstet Gynecol; 2000 Dec; 183(6):1489-94. PubMed ID: 11120516 [TBL] [Abstract][Full Text] [Related]
42. Circulating levels of thrombospondin-1 are decreased in HELLP syndrome. Stenczer B; Molvarec A; Szabó G; Szarka A; Fügedi G; Szijártó J; Rigó J Thromb Res; 2012 Apr; 129(4):470-3. PubMed ID: 22035632 [TBL] [Abstract][Full Text] [Related]
43. Comparison of perinatal and maternal outcomes of severe preeclampsia, eclampsia, and HELLP syndrome. Yıldırım G; Güngördük K; Aslan H; Gül A; Bayraktar M; Ceylan Y J Turk Ger Gynecol Assoc; 2011; 12(2):90-6. PubMed ID: 24591969 [TBL] [Abstract][Full Text] [Related]
44. Association of increased serum heat shock protein 70 and C-reactive protein concentrations and decreased serum alpha(2)-HS glycoprotein concentration with the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Molvarec A; Prohászka Z; Nagy B; Kalabay L; Szalay J; Füst G; Karádi I; Rigó J J Reprod Immunol; 2007 Apr; 73(2):172-179. PubMed ID: 17023052 [TBL] [Abstract][Full Text] [Related]
45. Midtrimester triple test levels in women with severe preeclampsia and HELLP syndrome. Shenhav S; Gemer O; Volodarsky M; Zohav E; Segal S Acta Obstet Gynecol Scand; 2003 Oct; 82(10):912-5. PubMed ID: 12956840 [TBL] [Abstract][Full Text] [Related]
46. Pregnancy complicated by preeclampsia-eclampsia with the syndrome of hemolysis, elevated liver enzymes, and low platelet count: how rapid is postpartum recovery? Martin JN; Blake PG; Lowry SL; Perry KG; Files JC; Morrison JC Obstet Gynecol; 1990 Nov; 76(5 Pt 1):737-41. PubMed ID: 2216215 [TBL] [Abstract][Full Text] [Related]
47. Serum levels of neopterin, tumor necrosis factor-alpha and Interleukin-6 in preeclampsia: relationship with disease severity. Ozler A; Turgut A; Sak ME; Evsen MS; Soydinc HE; Evliyaoglu O; Gul T Eur Rev Med Pharmacol Sci; 2012 Nov; 16(12):1707-12. PubMed ID: 23161044 [TBL] [Abstract][Full Text] [Related]
48. [Up-to-date on the HELLP syndrome (Hemolysis, Elevated Liver enzymes and Low Platelets)]. Medhioub Kaaniche F; Chaari A; Turki O; Rgaieg K; Baccouch N; Zekri M; Bahloul M; Chelly H; Ben Hamida Ch; Bouaziz M Rev Med Interne; 2016 Jun; 37(6):406-11. PubMed ID: 26774917 [TBL] [Abstract][Full Text] [Related]
51. Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum. Swinkels DW; de Kok JB; Hendriks JC; Wiegerinck E; Zusterzeel PL; Steegers EA Clin Chem; 2002; 48(4):650-3. PubMed ID: 11901066 [No Abstract] [Full Text] [Related]
52. Placental localization and expression of the cell death factors BNip3 and Nix in preeclampsia, intrauterine growth retardation and HELLP syndrome. Stepan H; Leo C; Purz S; Höckel M; Horn LC Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):172-6. PubMed ID: 16219518 [TBL] [Abstract][Full Text] [Related]
53. Serum soluble Fas in the syndrome of hemolysis, elevated liver enzymes, and low platelets. Harirah H; Donia SE; Hsu CD Obstet Gynecol; 2001 Aug; 98(2):295-8. PubMed ID: 11506848 [TBL] [Abstract][Full Text] [Related]
54. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome versus severe preeclampsia: onset at < or =28.0 weeks' gestation. Haddad B; Barton JR; Livingston JC; Chahine R; Sibai BM Am J Obstet Gynecol; 2000 Dec; 183(6):1475-9. PubMed ID: 11120513 [TBL] [Abstract][Full Text] [Related]
55. Long-term maternal and subsequent pregnancy outcomes 5 years after hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome. Habli M; Eftekhari N; Wiebracht E; Bombrys A; Khabbaz M; How H; Sibai B Am J Obstet Gynecol; 2009 Oct; 201(4):385.e1-5. PubMed ID: 19716544 [TBL] [Abstract][Full Text] [Related]
56. Oral N-acetylcysteine administration does not stabilise the process of established severe preeclampsia. Roes EM; Raijmakers MT; Boo TM; Zusterzeel PL; Merkus HM; Peters WH; Steegers EA Eur J Obstet Gynecol Reprod Biol; 2006 Jul; 127(1):61-7. PubMed ID: 16243427 [TBL] [Abstract][Full Text] [Related]
57. [Labor complications of the HELLP syndrome without any predictive factors]. Debette M; Samuel D; Ichai P; Sebagh M; Saliba F; Bismuth H Gastroenterol Clin Biol; 1999 Feb; 23(2):264-7. PubMed ID: 10353020 [TBL] [Abstract][Full Text] [Related]
58. Total and Fetal Circulating Cell-Free DNA, Angiogenic, and Antiangiogenic Factors in Preeclampsia and HELLP Syndrome. Muñoz-Hernández R; Medrano-Campillo P; Miranda ML; Macher HC; Praena-Fernández JM; Vallejo-Vaz AJ; Dominguez-Simeon MJ; Moreno-Luna R; Stiefel P Am J Hypertens; 2017 Jul; 30(7):673-682. PubMed ID: 28338787 [TBL] [Abstract][Full Text] [Related]
59. Factors that influence morbidity and mortality in severe preeclampsia, eclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome. Demir SC; Evruke C; Ozgunen FT; Urunsak IF; Candan E; Kadayifci O Saudi Med J; 2006 Jul; 27(7):1015-8. PubMed ID: 16830022 [TBL] [Abstract][Full Text] [Related]
60. Maternal immune suppression during pregnancy does not prevent abnormal behavior in offspring. Griffin A; Bowles T; Solis L; Railey T; Beauti S; Robinson R; Spencer SK; Shaffery JP; Wallace K Biol Sex Differ; 2024 Mar; 15(1):27. PubMed ID: 38532505 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]